Dianthus Therapeutics, Inc.
USD105.60
+10.25 (+10.75%)
CEO
Marino Garcia
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$93.33
Prev. Close
$95.35
Day Low
$91.01
Day High
$105.74
52W Low
$18.08
52W High
$105.72
Market Cap
$4.41B
Volume
1.03M
| 10,354 |
| $100.22 |
| 13 Jul 2026 | Savitz Ryan | EVP, CFO & CBO | S-Sale | Disposed | 15,329 | $101.24 |
| 13 Jul 2026 | Savitz Ryan | EVP, CFO & CBO | S-Sale | Disposed | 5,566 | $101.97 |
| 13 Jul 2026 | Savitz Ryan | EVP, CFO & CBO | M-Exempt | Disposed | 31,249 | $21.77 |
| 18 Jun 2026 | Veness Adam M | SVP, General Counsel and Sec. | M-Exempt | Acquired | 30,000 | $17.88 |
| 18 Jun 2026 | Veness Adam M | SVP, General Counsel and Sec. | S-Sale | Disposed | 16,771 | $80.34 |
| 18 Jun 2026 | Veness Adam M | SVP, General Counsel and Sec. | S-Sale | Disposed | 13,229 | $81.38 |
| 18 Jun 2026 | Veness Adam M | SVP, General Counsel and Sec. | M-Exempt | Disposed | 30,000 | $17.88 |
| 2 Jun 2026 | Randhawa Simrat | EVP, Head of R&D | M-Exempt | Acquired | 3,998 | $8.44 |